HEG Independent Director Dr. Khaitan buys 5,000 shares for ₹33.31 lakh
HEG Limited reported that Independent Director Dr. Nand Gopal Khaitan bought 5,000 shares for ₹33.31 lakh on August 3, 2026. The market purchase on the NSE raises his stake to 0.0026%. The disclosure complies with SEBI's insider trading regulations.

*this image is generated using AI for illustrative purposes only.
HEG Limited disclosed that Dr. Nand Gopal Khaitan, its Independent Director, purchased 5,000 equity shares in the company on August 3, 2026. The acquisition, executed through a market purchase on the National Stock Exchange (NSE), was valued at ₹33,31,810, translating to a price of ₹665.44 per share. This transaction brings Dr. Khaitan’s total holding to 5,000 shares, representing 0.0026% of the company’s total equity share capital.
The disclosure was made under Regulation 7(2) read with Regulation 6(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015. HEG Limited received the requisite intimation from Dr. Khaitan on August 4, 2026, and subsequently notified both the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE). The filing confirms that the director held nil securities prior to this acquisition.
Transaction Details
The specifics of the share purchase are outlined below:
| Parameter | Detail |
|---|---|
| Director Name | Dr. Nand Gopal Khaitan |
| Designation | Independent Director |
| DIN | 00020588 |
| Transaction Type | Purchase |
| Number of Shares | 5,000 |
| Total Value | ₹33,31,810 |
| Price Per Share | ₹665.44 |
| Exchange | National Stock Exchange (NSE) |
| Date of Acquisition | August 3, 2026 |
| Post-Transaction Holding | 5,000 shares (0.0026%) |
Dr. Khaitan’s PAN is recorded as AFLPK3827K in the filing. The value of the transaction excludes taxes, brokerage, and other charges as per standard reporting norms under the SEBI PIT Regulations. There were no derivatives transactions reported alongside this equity purchase.
What the Numbers Show
The purchase by an independent director often signals confidence in the company’s future prospects or fair valuation at current market levels. With a holding of just 0.0026%, this remains a relatively small stake, but insider buying activity is closely monitored by investors as a potential indicator of management sentiment regarding the stock’s intrinsic value. The transaction was completed entirely on the open market, ensuring transparency in the execution.
Historical Stock Returns for HEG
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +2.06% | +4.05% | +28.86% | +25.60% | +28.04% | +44.38% |
Will other board members or executives follow Dr. Khaitan's lead and increase their equity stakes in HEG Limited?
How might this insider purchase influence retail investor sentiment and short-term trading volume in HEG shares?
Does this acquisition suggest that management believes the current market price of ₹665.44 represents a significant undervaluation?


































